vs

Side-by-side financial comparison of BAR HARBOR BANKSHARES (BHB) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

BAR HARBOR BANKSHARES is the larger business by last-quarter revenue ($48.9M vs $34.2M, roughly 1.4× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 24.0%, a 34.8% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 27.3%). BAR HARBOR BANKSHARES produced more free cash flow last quarter ($43.5M vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 15.9%).

Bar Harbor Bankshares is a U.S. regional bank holding company headquartered in Maine. It offers retail and commercial banking services including deposit products, personal and business loans, wealth management, and mortgage solutions, mainly serving customers across Maine, New Hampshire, and Vermont.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BHB vs DTIL — Head-to-Head

Bigger by revenue
BHB
BHB
1.4× larger
BHB
$48.9M
$34.2M
DTIL
Growing faster (revenue YoY)
DTIL
DTIL
+5233.9% gap
DTIL
5261.1%
27.3%
BHB
Higher net margin
DTIL
DTIL
34.8% more per $
DTIL
58.9%
24.0%
BHB
More free cash flow
BHB
BHB
$54.7M more FCF
BHB
$43.5M
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
15.9%
BHB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BHB
BHB
DTIL
DTIL
Revenue
$48.9M
$34.2M
Net Profit
$11.8M
$20.1M
Gross Margin
Operating Margin
30.1%
36.6%
Net Margin
24.0%
58.9%
Revenue YoY
27.3%
5261.1%
Net Profit YoY
6.9%
213.5%
EPS (diluted)
$0.71
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHB
BHB
DTIL
DTIL
Q4 25
$48.9M
$34.2M
Q3 25
$47.5M
$13.0K
Q2 25
$34.5M
$18.0K
Q1 25
$37.9M
$29.0K
Q4 24
$38.5M
$638.0K
Q3 24
$38.6M
$576.0K
Q2 24
$37.2M
$49.9M
Q1 24
$36.4M
$17.6M
Net Profit
BHB
BHB
DTIL
DTIL
Q4 25
$11.8M
$20.1M
Q3 25
$8.9M
$-21.8M
Q2 25
$6.1M
$-23.5M
Q1 25
$10.2M
$-20.6M
Q4 24
$11.0M
Q3 24
$12.2M
$-16.4M
Q2 24
$10.3M
$32.7M
Q1 24
$10.1M
$8.6M
Operating Margin
BHB
BHB
DTIL
DTIL
Q4 25
30.1%
36.6%
Q3 25
23.2%
-158976.9%
Q2 25
21.6%
-121538.9%
Q1 25
33.5%
-76248.3%
Q4 24
35.2%
Q3 24
35.3%
-3693.6%
Q2 24
34.4%
48.4%
Q1 24
34.8%
-23.8%
Net Margin
BHB
BHB
DTIL
DTIL
Q4 25
24.0%
58.9%
Q3 25
18.6%
-167476.9%
Q2 25
17.6%
-130666.7%
Q1 25
26.9%
-70913.8%
Q4 24
28.6%
Q3 24
31.6%
-2851.6%
Q2 24
27.6%
65.6%
Q1 24
27.7%
48.8%
EPS (diluted)
BHB
BHB
DTIL
DTIL
Q4 25
$0.71
$2.62
Q3 25
$0.54
$-1.84
Q2 25
$0.40
$-2.13
Q1 25
$0.66
$-2.21
Q4 24
$0.71
Q3 24
$0.80
$-2.25
Q2 24
$0.67
$4.67
Q1 24
$0.66
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHB
BHB
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$80.8M
$115.6M
Total DebtLower is stronger
$134.8M
Stockholders' EquityBook value
$532.5M
$92.2M
Total Assets
$4.7B
$154.4M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHB
BHB
DTIL
DTIL
Q4 25
$80.8M
$115.6M
Q3 25
$136.7M
$44.9M
Q2 25
$87.0M
$62.2M
Q1 25
$88.1M
$77.2M
Q4 24
$72.2M
$86.3M
Q3 24
$81.2M
$101.2M
Q2 24
$101.8M
$123.6M
Q1 24
$76.2M
$137.8M
Total Debt
BHB
BHB
DTIL
DTIL
Q4 25
$134.8M
Q3 25
$134.6M
Q2 25
$40.9M
Q1 25
$40.9M
Q4 24
$40.9M
Q3 24
$60.9M
Q2 24
$60.8M
Q1 24
$60.8M
Stockholders' Equity
BHB
BHB
DTIL
DTIL
Q4 25
$532.5M
$92.2M
Q3 25
$521.0M
$16.6M
Q2 25
$468.9M
$34.1M
Q1 25
$467.3M
$49.3M
Q4 24
$458.4M
$56.4M
Q3 24
$459.9M
$64.9M
Q2 24
$438.9M
$74.7M
Q1 24
$435.7M
$37.2M
Total Assets
BHB
BHB
DTIL
DTIL
Q4 25
$4.7B
$154.4M
Q3 25
$4.7B
$93.5M
Q2 25
$4.1B
$108.9M
Q1 25
$4.1B
$124.4M
Q4 24
$4.1B
$136.4M
Q3 24
$4.0B
$153.3M
Q2 24
$4.0B
$165.8M
Q1 24
$4.0B
$184.7M
Debt / Equity
BHB
BHB
DTIL
DTIL
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.09×
Q1 25
0.09×
Q4 24
0.09×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHB
BHB
DTIL
DTIL
Operating Cash FlowLast quarter
$48.3M
$-11.3M
Free Cash FlowOCF − Capex
$43.5M
$-11.3M
FCF MarginFCF / Revenue
88.8%
-32.9%
Capex IntensityCapex / Revenue
9.8%
0.1%
Cash ConversionOCF / Net Profit
4.10×
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$70.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHB
BHB
DTIL
DTIL
Q4 25
$48.3M
$-11.3M
Q3 25
$16.5M
$-15.3M
Q2 25
$5.3M
$-20.3M
Q1 25
$9.3M
$-19.1M
Q4 24
$52.4M
$-58.4M
Q3 24
$23.5M
$-5.9M
Q2 24
$7.1M
$-14.9M
Q1 24
$8.5M
$-19.0M
Free Cash Flow
BHB
BHB
DTIL
DTIL
Q4 25
$43.5M
$-11.3M
Q3 25
$15.4M
Q2 25
$3.3M
$-20.3M
Q1 25
$7.8M
$-19.1M
Q4 24
$45.0M
$-58.7M
Q3 24
$22.4M
$-6.0M
Q2 24
$2.3M
$-14.9M
Q1 24
$7.8M
$-19.1M
FCF Margin
BHB
BHB
DTIL
DTIL
Q4 25
88.8%
-32.9%
Q3 25
32.5%
Q2 25
9.5%
-112627.8%
Q1 25
20.5%
-65917.2%
Q4 24
116.9%
-9199.8%
Q3 24
58.1%
-1033.2%
Q2 24
6.1%
-29.9%
Q1 24
21.5%
-108.4%
Capex Intensity
BHB
BHB
DTIL
DTIL
Q4 25
9.8%
0.1%
Q3 25
2.3%
0.0%
Q2 25
5.8%
11.1%
Q1 25
4.1%
220.7%
Q4 24
19.2%
39.2%
Q3 24
2.7%
6.8%
Q2 24
12.9%
0.1%
Q1 24
1.8%
0.5%
Cash Conversion
BHB
BHB
DTIL
DTIL
Q4 25
4.10×
-0.56×
Q3 25
1.87×
Q2 25
0.86×
Q1 25
0.91×
Q4 24
4.76×
Q3 24
1.93×
Q2 24
0.69×
-0.45×
Q1 24
0.84×
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons